(ISSN 2577-5820)
OBM Transplantation (ISSN 2577-5820) is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc., which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.
OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.
The journal publishes all types of articles in English. There is no restriction on the length of the papers. We encourage authors to be concise but present their results in as much detail as necessary, as reviewers are expected to emphasize scientific rigor and reproducibility.
Publication Speed (median values for papers published in 2023): Submission to First Decision: 6.7 weeks; Submission to Acceptance: 14.4 weeks; Acceptance to Publication: 6 days (1-2 days of FREE language polishing included)
We recommend using our Microsoft Word and LaTeX templates for your manuscript preparation. When preparing manuscripts, please refer to Research Publication: International Standards for Authors and our Research and Publication Ethics Guidelines.
A cover letter, the manuscript (including the title page, figures, tables, and boxes inserted within the main text), and any supplementary or supporting materials (such as additional figures and tables, datasheets, videos, etc.) if applicable, are required for submission. Please note that manuscripts may only be submitted by one of the authors of the manuscript and not by third parties.
The title of a manuscript should be a concise, specific and informative noun phrase. Abbreviations or formulae should be avoided where possible.
Please ensure that each author meets the authorship criteria of the journal.
Authors’ full first and last names must be provided. The initials of any middle names are optional. At least one author should be designated as corresponding author. The email addresses of all authors should be provided in the manuscript.
Each author must be affiliated to at least one institute. If author’s affiliation has changed after the study was finished and before the paper was accepted, current affiliation should be indicated as well. The affiliation should be organized in the style: Department, University/Organizational affiliation, City, State/Province (if applicable), Country. After obtaining the results of peer review, please avoid radical changes to the institute information.
The abstract should be as brief as no more than 300 words or less and should succinctly state the purpose and main methods or experiments applied of the study, main findings, and the main conclusions or potential implications drawn from the study. Please minimize the use of abbreviations, and avoid citations in the abstract (any reference to other works should be described in the Abstract and cited in the main text).
Authors are encouraged to provide a graphical figure or photo as a Graphic Abstract, which will serve as a visual summary of the research. This Graphic Abstract will be published on the website alongside the paper and should effectively illustrate the research theme, subjects, design, conclusions, and highlight the key findings of the study.
Static and GIF images are both acceptable. Pictures minimum of 300 dpi are preferred.
Each manuscript must contain 3 to 10 keywords that be pertinent to the subject.
This section provides an overview of the research background, outlining the objectives and significance of the study in relation to existing research in the field. It should clearly state the working hypothesis or hypotheses that will be addressed in the research.
This section provides a comprehensive description of the research methodology to enable others to replicate the work. For novel methods, a detailed description is required, while well-established methods can be briefly summarized or referenced appropriately. It is essential to clearly explain the resources, materials, data, and protocols used in the study, particularly for those with restricted access. The names of suppliers for all antibodies used in the study should be provided. Additionally, the methods of statistical analysis should be clearly identified, and any statistical software programs used in the study should be appropriately cited.
The research conducted should adhere to the Research and Publication Ethics Guidelines. It is required to include a dedicated section in the manuscript called "Ethics Statement." This section should demonstrate that the research was approved by an appropriate ethics committee or an equivalent institution and that it was conducted in an ethical manner. If identifiable information from human subjects has been used, it is necessary to state in the disclosure that written Informed Consent has been obtained from the subjects for the release of such information.
If your manuscript is not applicable to this requirement, please include "Not applicable" in this section. The Ethics Statement should provide, at minimum, the project identification code, date of approval, and the name of the ethics committee or institutional review board involved in the approval process.
It presents the experimental findings. Tables and figures may be included in this section.
Figures in EPS, JPG, PNG, PDF, and TIFF formats are acceptable. Please ensure that Line Art has a resolution of 1200 dpi, Combo images have a resolution of 600 dpi, and Halftone images have a resolution of 300 dpi. Color figures are preferred while not charged. For image quality requirements, please refer to the Image Quality Specification
All figures in the manuscript should have a concise noun title and a concise explanatory caption. Footnotes should be clearly marked and explained.
Figures should be sequentially ordered in numerical order (e.g., Figure 1 or Figure 1A) throughout the paper and inserted in the text near their first citation.
Tables should be prepared in editable Word format, instead of inserted pictures or pieced text.
All tables should contain a brief noun title while all columns should be given an explanatory heading. Footnotes should be clearly and correctly marked and explained.
Tables should be sequentially ordered in numerical order (e.g. Table 1) throughout the paper and inserted in the text near their first citation.
Equations contained in the manuscript should be prepared by equation editors, e.g., Microsoft Equation Editor built in Word, instead of inserted pictures or pieced text.
The findings and their implications should be discussed and/or compared with those of other studies. Future research directions may also be recommended in this section.
This is an optional section, which can be included if the discussion is very long or complicated.
In addition to the main authors, those who provided help during the research (e.g., language check, writing assistance, etc.) should be thanked in this section.
A section on Author Contributions should be included, specifying the contributions made by each author. The journal adopts CRediT (Contributor Role Taxonomy) to describe each author’s individual contributions to the work. An example of the Author Contributions statement:
Author Name: Conceptualization, writing – original draft, formal analysis, writing – review and editing. Author Name: Software, writing – review and editing. Author Name: Methodology, writing – review and editing. Author Name: Conceptualization, writing – original draft, writing – review and editing. All authors have read and approved the published version of the manuscript.
If the manuscript has a single author, it is necessary to include the statement "The author conducted all the research work for this study" in this section. Please refer to the CRediT taxonomy for an explanation of the above terms.
Funding resources and grant information should be clarified in this section.
All authors are required to disclose any potential conflicts of interest. Authors must disclose any financial or personal relationships with individuals or organizations that could potentially influence or bias their work inappropriately. For detailed requirements, please refer to the Competing Interests Policy for specific instructions.
Sample disclosure statements of competing interests:
Authors may refer to the following template: “Author A has received research sponsorship from Company A. Author B is the inventor of Patent B (Patent No. xxx, Patent Name xxx). Author C owns stock in Company C. We have fully disclosed any and all interests to LIDSEN.”
Authors should state "The authors have declared that no competing interests exist."
Authors should describe where the research data associated with a paper is available and how it can be accessed in this section, including hyperlinks and persistent identifiers (e.g. DOI or accession number) if applicable. The data can be primary data (data the authors generated as part of their study) or secondary data (data from other sources that the authors reused in their study).
The International Committee of Medical Journal Editors (ICMJE) provides further guidance on how to compose a rich statement. Our Data Sharing and Citation Policy also provides some examples of Data Availability Statement.
To support or supplement the study, additional materials, e.g., text documents, data tables and spreadsheets, static and GIF images, videos, etc., can be published along with the paper. A list of the materials should be provided in the paper, like:
The following additional materials are uploaded at the page of this paper:
References, throughout the text, including tables and legends, should be numbered in numerical order. Citation numbers should be included in square brackets ([ ], like [1], [2, 3], [4-8]).
Reference manager, like EndNote, is recommended if a manuscript, especially review article, contains a large number of references. An Vancouver style EndNote template can be downloaded here.
LIDSEN journals follow Vancouver citation style. Frequently used reference types are listed below. For more detailed instructions and examples, please visit: International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals: Sample References and Citing Medicine, 2nd edition.
We have provided examples of references in the following categories for your convenience and reference:
Author 1 AB, Author 2 CD. (up to 6 authors before using “et al.”) Article title. Abbreviated Journal Name. Year; Volume: pages. (When page is not available, a DOI or other identifier should be provided).
Author 1 AB, Author 2 CD. Book title. 2nd ed. City of the Publisher: Name of the Publisher; Year of the publication. (page p. or p. page range if any. For example, p. 254, pp. 254-259, 480p.).
Author 1 AB; Author 2 CD. Chapter title. In: Book title. City of the Publisher: Name of the Publisher; Year of the publication. (page p. or p. page range if any).
Author 1 AB, Author 2 CD. Title of the presentation. Proceedings of the Name of the Conference; Full Date of Conference (Year Month Day); Location of Conference (City, State if US, Country). Location of the Publisher (City): Name of the Publisher.
Author 1 AB, Author 2 CD. Report title. Final report. City of the report agency (state abbreviation if US): Name of the agency; year of the report; report number.
Author AB. Title of thesis. City of the University: Name of the university; year of completion.
Author 1 AB, Author 2 CD. Article title [Internet]. City of the press: name of the press; year of update [cited date (year month day)]. Available from: URL.
Author 1 AB, Author 2 CD. Title of unpublished work. Abbreviated Journal. Forthcoming year.
The manuscript will undergo a preliminary check by the external Academic Editor to ensure it aligns with the scope and meets the quality and relevance requirements of the journal. The external academic editor will be the Editor-in-Chief or an Editorial Board member with the appropriate background in the case of regular submissions, and the Guest Editor in the case of Special Issue submissions. Only after this initial check, the paper will be sent for peer review. Supplementary materials are also subjected to peer review.
This journal executes single-blind peer review which means reviewers are anonymous. Manuscripts deemed suitable will be reviewed by external experts invited by the internal assistant editor. External experts include volunteer reviewers, members of the Reviewer Board and Editorial Board, or those suggested by the academic editors. Reviewers recommended by authors may also consider. Reviewers should not have published with any of the co-authors during the past three years and should not currently work or collaborate with any of the institutions of the co-authors of the submitted manuscript. After the authors have made revisions and submitted the revised manuscript, the same reviewers will be contacted to review the revised version. Please be aware that the journal editors agree to defend the confidentiality of authors and peer-reviewers following ICMJE policy. All material will be handled in confidence except for the purposes of review and to investigate possible misconduct.
In rare cases, despite extensive efforts and numerous invitations, it may not be possible to obtain the required number of reviewers. In such cases, it may be suggested to withdraw the manuscript rather than further delaying its processing, allowing authors to approach other publishers who may have a better chance of finding suitable reviewers.
Currently, manuscript types such as Editorials and Interviews do not undergo the peer review process in this journal. The manuscript types mentioned above will be subjected to assessment by the Editor-in-Chief, Guest Editor, or members of the Editorial Board upon submission. Following this review, a determination will be made regarding the manuscript's appropriateness for publication. Except for the two manuscript types mentioned above, all other types of manuscripts submitted to the journal, including those submitted for a special issue, will always undergo the peer-review process. Please read the detailed Editorial Process here.
The journal allows authors to correct their authorship in cases where there are legitimate reasons. Any additions, deletions, or rearrangements of names in the author list can only be made prior to publication. Any modifications require confirmation from all authors, including those being added or removed, and should be communicated to the responsible journal editor. Authorship changes will not be considered if confirmation from all authors cannot be provided.
If a manuscript is rejected by the journal for not meeting the established interest level, but aligns with the research scope of another journal within LIDSEN, authors have the option to transfer the manuscript to the appropriate journal. Please note that accepting the transfer offer does not guarantee acceptance of the manuscript, as the editors of the journal will still need to evaluate it thoroughly.
Once the Editor-in-Chief, Editorial Board, or Guest Editor of the special issue has made a decision to accept your manuscript, you will receive an acceptance letter. Subsequently, you will receive the word version of the galley proof for your review and approval. We kindly request authors to carefully review the edits and formatting made during the editing and typesetting process to ensure the accuracy of the material. It is recommended to minimize the number of revisions and modifications and focus on correcting any errors. Authors are also requested to promptly respond to any inquiries from the editorial team. When reviewing the galley proof, please highlight any necessary modifications or corrections to ensure they are easily identifiable.
Debate post-publication is allowed on the journal website, through Letter to Editor or Comment. The journal encourages you to contact the Editorial Office when you identify errors and ethical issues in a published article. The Editorial Office will carefully investigate and address it following the COPE guidelines and update the published article when necessary.
Any necessary changes will be accompanied by a post-publication notice, such as a Correction, a Retraction, an Expression of Concern, a Comment and Reply and in rare circumstances a Removal, that will be permanently linked back to the original article. All these notices will be published for free. Please visit our full policy on updating published papers.
As a member of COPE (Committee on Publication Ethics), the OBM Transplantation editorial team has undergone comprehensive training to enforce rigorous peer-review processes and uphold stringent ethical policies and standards.
By submitting a manuscript to our journal, all authors affirm that they have read and consented to the editorial policies and that the manuscript aligns with the journal's relevant policies and guidelines.
2023 | ||
CiteScore | SJR | SNIP |
0.6 | 0.179 | 0.17 |
TOP